[{"Assets_0_Q3_USD":43010400000.0,"EarningsPerShareBasic_1_Q3_USD":0.53,"EarningsPerShareBasic_3_Q3_USD":1.38,"EarningsPerShareDiluted_1_Q3_USD":0.53,"EarningsPerShareDiluted_3_Q3_USD":1.37,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":3872100000.0,"NetIncomeLoss_1_Q3_USD":555600000.0,"NetIncomeLoss_3_Q3_USD":1452800000.0,"StockholdersEquity_0_Q3_USD":14890300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1056000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1057000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1053400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1054800000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282856619893.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20171027"}]